Introduction {#S1}
============

With increasing life expectancy, the growing proportion of elderly populations across the world has made osteoporosis an increasingly important public health issue ([@B57]). Two hundred million individuals are affected by osteoporosis worldwide ([@B41]), causing 8.9 million fractures yearly (1,000 fractures per hour), with the hip injury being the most debilitating ([@B26]). This issue is also associated with other health problems such as pain, hospitalisation, surgery, loss of independence and premature death ([@B25]). On this basis, the prevention and treatment of osteoporosis are of utmost importance in public health ([@B7]), implying the need for more research to find ways to reduce the related financial burden ([@B63]).

Several studies suggested regular physical activity as an effective tool to prevent effects of ageing ([@B19]; [@B46]) and improve the bone health ([@B32]). Whole-body vibration (WBV) training may represent an alternative to current methods to fight bone disorders and to reduce the risk of impact injuries ([@B35]). This type of activity, which can be generated with different platforms (vertical, rotational or lateral modes) ([@B34]) generates forces that are transferred to the weight-bearing bones of the skeleton as done by other exercise modalities ([@B12]). So, WBV exercises could have beneficial effects associated with bone formation and the neuromuscular and cognitive functions, reducing the risk of falls and fractures ([@B37]; [@B6]). However, several authors reported conflicting results due to the variety of protocols used ([@B32]). Some studies have included protocols with frequencies at 10--15 Hz to allow for gentle adaptation in frail populations (elderly or rehabilitation programs, etc.) ([@B23]; [@B56]; [@B58]). These investigations reported a clinically relevant effect in bone loss prevention at the femoral neck and lumbar spine. Although the frequency is important, the duration of WBV intervention plays an important role ([@B23]). Authors suggested a dose-response relationship between vibration exposure and reduced bone resorption ([@B56]). A minimum of three times per week and six months' duration could be necessary to obtain improvements in bone mass ([@B23]; [@B19]; [@B59]). Activity levels tend to progressively decrease with age; the inactivity is higher among older adults ([@B48]). So, a high frequency and duration of training could be inconvenient for the elderly population, which is unable or reluctant to do exercise due to lack of sufficient motivation or interest ([@B20]; [@B45]). Variability within the available systems of vibration and lack of consensus on the WBV training protocol result in the conflicting evidence for efficacy on bone health ([@B17]; [@B34]). The optimal dose of vibration exercise that is needed to increase BMD in humans has yet to be defined ([@B28]). Other drawbacks of this type of exercise is that benefits have only been found in the hip or lower body ([@B32]). Therefore, the combination of effects of WBV training with other therapies could provide a new mode of osteoporosis prevention and treatment.

Therapeutic benefits of hypoxic training have been suggested for clinical populations such as the elderly ([@B36]). Development of exercise in a hypoxic environment could enhance the physiological experience of training ([@B49]), being a safe and non-invasive strategy for elderly adults ([@B4]).

Previous studies have combined cyclic hypoxia and strength training in the elderly population to determine the effects on different parameters, such as muscle strength ([@B47]; [@B10]), cognitive performance and postural stability ([@B53]). Regarding bone parameters, two previous studies applied hypoxia training in healthy active or trained subjects; they showed increased or maintained bone mineral density (BMD) after 8 and 7 weeks, respectively ([@B40]; [@B33]). To the best of our knowledge, the combined effects of WBV training and hypoxic exposure on health parameters have not been investigated. Additional studies are needed to determine the optimal cyclical dose that could have beneficial effects on bone systems.

In the bone microenvironment, which is physiologically hypoxic, various genes downstream of HIF mediate different effects ([@B15]). Hypoxia-regulated transcription activates genes and pathways that reduce oxygen consumption and the cellular dependence on oxygen ([@B51]). On the other hand, HIF-regulated genes induce angiogenesis and erythropoiesis to increase the tissue oxygen supply; it even stimulates bone formation ([@B15]). However, different modes of hypoxic exposure may lead to different impacts on bone metabolism ([@B11]). While sustained ([@B2]; [@B3]; [@B44]; [@B39]) and intermittent hypoxia ([@B55]; [@B54]) related to obstructive sleep apnoea might inhibit osteogenic differentiation and promote osteoclast function, cyclical hypoxia has been presented as a promising strategy to beneficially impact bone metabolism ([@B22]; [@B60]). In this way, the combining of WBV training and cyclic hypoxic exposure could augment the beneficial effects of WBV training, resolve the inconvenience of long training periods, and ensure that the bone benefits aren't just localised.

Considering all these findings, the present study investigated the effects of normobaric cyclic hypoxic exposure combined with WBV training on BMD of the elderly (age \> 65 years) over an 18-week period. We hypothesised that WBV training with hypoxic stimuli would maintain or increase BMD compared to WBV training or resting in normoxia.

Materials and Methods {#S2}
=====================

Study Design {#S2.SS1}
------------

This was a randomised double-blind controlled study. There were separate intervention and assessment teams. We tried to blind the study for participants, as they were trained/tested separately. During 18 weeks the volunteers completed 36 training sessions supervised by an experienced member of the research group. The frequency of training was twice a week; sessions were scheduled with at least one day of rest in between for optimal recovery. All patients were assessed at two time points by a group of researchers, who were blinded to the treatment assignment. Outcomes were measured at baseline (Pre) before the 18 weeks of intervention and reassessed 7 days after the last session (Post). Participants were instructed to abstain from participating in any other type of physical exercise during the duration of this trial.

Participants {#S2.SS2}
------------

The voluntary participation of elderly subjects was requested by letter and verbal communication at the Senior Universities and pensioners' associations of Évora (Portugal). Inclusion criteria, assessed during a screening visit, were: (1) women and men aged 65 years or older, (2) absence of participation in any other type of intervention based on physical exercise in the last 6 months in order to avoid interactions with the previous practice, (3) subjects have not been above 1500 m during the last 3 months, (4) no current medical condition not compatible with planned exercise, (5) free of illness or medication potentially affecting the bone system, (6) estimated daily calcium intake of 500 mg/day or more and (7) consumption of no more than four alcoholic beverages per week. Exclusion criteria were mainly based on contra indications for WBV (severe cardiovascular diseases, ocular diseases that affect the retina, neuromuscular and heart diseases, stroke, implant, bypass, stent, arthritis and other joint disease or epilepsy) or a frequency of participation in the stipulated program lower 80% (participants who missed more than 20% of training sessions were excluded).

Forty-six volunteers (13 males and 33 females) were informed about the study procedures and were requested to sign a declaration that they voluntarily consented to participate in this research. The eligible volunteers, who met the inclusion criteria (*n* = 43; age: 72 ± 5.3 years; BMI: 29 ± 4.2 kg⋅m-2;% fat: 36.5 ± 8.2; BMD: 1.069 ± 0.115 g⋅cm-2), were randomly divided into three groups, by simple randomisation: (1) Hypoxia Whole Body Vibration group (HWBV; *n* = 14), who performed whole body vibration treatment under normobaric hypoxic conditions; (2) Normoxic Whole Body Vibration group (NWBV; *n* = 14), who performed whole body vibration treatment under normoxic conditions; and (3) Control group (CON; *n* = 15), who were instructed to continue with their normal daily activities for the entire duration of the study ([Figure 1](#F1){ref-type="fig"}).

![Flow of participants through each stage of the trial. HWBV, hypoxia whole body vibration group. NWBV, normoxia whole body vibration group; CON, control group; F, female; M, male.](fphys-10-01122-g001){#F1}

All procedures were performed in studies involving human participants were in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards and the study design was approved by the Bioethical and Biosecurity Commission of the University of Extremadura (17/2016).

Training Protocol {#S2.SS3}
-----------------

During sessions, HWBV and NWBV groups performed the vibration exercise in a standing position, with feet side by side on specific landmark in the board and barefoot to eliminate any damping of the vibration caused by footwear ([@B23]). The angle of flexion of the knee during the vibration exercise was set at 120°, which were established with goniometer. The participants were allowed to hold the vibration platform with their hands ant the intervention was supervised by an experienced member of the research group for correct postural control. Vibration stimulus (12.6 Hz) was produced and provided by a sinusoidal vibration platform (Galileo 2000, Novotec GmbH, Pforzheim, Germany) and the distant position form the axis of rotation was 4 mm peak-to-peak. The effective acceleration (a; 2.55 g force) was calculated using frequency (f in hertz) and displacement (d in metres) provided by the manufacturer according to the equation: *a* = (2π*f*)^2^*d* ([@B21]). Units of this equation are g that represents the Earth's gravitational acceleration at 9.81 m/s^2^. Subjects performed four sets of 30 s of vibration per session, separated by 60 s of rest. The total duration of the training session was about 16 min, which included a 10-min warm-up with 5 min bicycling at 25--50 W and 40--50 rpm and another 5 min of stretching exercises. All of this took place in a hypoxia chamber (CAT 310, Lousiville, Colorado, United States) placed in the laboratory.

For the HWBV group, fraction of inspired oxygen (FiO~2~) was set to 16.1% (0.16) to simulate an altitude of 2500 m above sea level; FiO2 was controlled regularly with an electronic device (HANDI+, Maxtec, Salt Lake City, Utah, United States). In order to blind subjects to altitude, the system was also run for the NWBV group with normoxic airflow into the chamber (up to 1000 l/min) and produced the same audible noise as in the hypoxic condition. NWBV subjects inspired FiO~2~ of 21.0% (0.21) to simulate an altitude of 459 m above sea level. Furthermore, all systems were covered with fabric to prevent participants from visually identifying the normoxic or hypoxic conditions.

At each session, peripheral oxygen saturation (SpO~2~) was controlled using a finger pulse-oximeter (Konica Minolta, Japan) and heart rate (HR) using a heart rate monitor (Polar team 2, Polar, Finland) to know the physiological challenge posed on the participants in different times of the session. Above parameters were controlled during the second minute of the warm-up (warm-up), previously to the start of the whole-body vibration protocol (pre-training), between the second and the third set of the whole body vibration protocol (mid-training) and after the whole body vibration protocol (post-training).

Measurements {#S2.SS4}
------------

### Socio-Demographic Data and Lifestyle Questionnaires {#S2.SS4.SSS1}

A general questionnaire was administered to collect medical and demographic data to check the inclusion/exclusion criteria. As control variables, prior and after the intervention, calcium intake was estimated using a food frequency questionnaire adapted to Portuguese traditional foods and dishes ([@B43]). The bone-specific physical activity questionnaire (B-PAQ) was used to assess the physical activity level of the participants in the last 12 months. Respondents recorded type, frequency and years of physical activity involvement to assess the effects of mechanical loading on the skeleton ([@B62]).

### Body Composition {#S2.SS4.SSS2}

Body composition variables such as percentage fat mass (CV = 2.1%) and percentage lean mass (CV = 1.7%) were obtained using dual-energy X-ray absorptiometry (DXA, Norland Excell Plus; Norland Inc., Fort Atkinson, United States). The same experienced technician performed all the scans, which were analysed by a graphical user interface (GUI) to Windows XP operating system. Body mass index (BMI) was determined per the accepted method (BMI = weight/height^2^, kg⋅m^--2^).

### BMD Assessment {#S2.SS4.SSS3}

BMD values from the whole body and right proximal femur (femur total, trochanter and intertrochanteric region) were assessed using DXA (CV = 1.9%). The same experienced technician performed all the scans, which were analysed by a graphical user interface (GUI) to Windows XP operating system. BMD was expressed in g⋅cm^--2^ and as the difference, expressed as standard deviations (SD), from the normal average value of peak bone mass at a participant's age. *T*-scores were calculated using the National Health and Nutrition Examination Study (NHANES) III BMD norms, as recommended by the World Health Organization for the diagnosis of osteoporosis in clinical practice ([@B31]).

### Compliance Training {#S2.SS4.SSS4}

Compliance training was calculated as the number of sessions completed divided by the 36 possible sessions available per participant.

Statistical Analysis {#S2.SS5}
--------------------

Statistical analyses were performed using the statistical analysis package SPSS v.20 for MAC (IBM, New York, United States). Standard statistical methods were used for the calculation of descriptive statistics as the mean and 95% Confidence Intervals. Kolmogorov--Smirnov tests were conducted to show the distribution of the studied variables and Levene's test for homogeneity of variance.

One-way analysis of variance (ANOVA) was used to compare differences across groups at baseline. Analysis of chi-square was also applied to evaluate differences between groups in the initial data on sex. Two-way repeated measures ANOVA with Bonferroni *post hoc* tests were used to investigate the main effects and the interaction between group-factor (control vs. normoxia vs. hypoxia) and time-factor (pre-training vs. post-training), considering the sex as covariate. The effect size ([@B13]) was calculated for all variables between baseline and after 18 weeks of intervention. The magnitude of change considered was trivial (\<0.5), small (0.5--1.25), moderate (1.26--1.99) or large (\>2.00) ([@B42]). Additionally, absolute change and the percentage change from pre- to post-test was calculated for all variables for each group, and the effects of the interventions were evaluated by pre-specifying the minimum detectable change (MDC). The MDC is an absolute measure of reliability (measurement error), which accounts for various sources of variability in defining a confidence interval in units of the measure. These values are being increasingly used to assist in interpreting results and determining whether a change between repeated tests is random variation or a true change in performance ([@B24]). An effect was considered relevant when the change was greater than MDC. The *p* \< 0.05 criterion was used for establishing statistical significance.

Results {#S3}
=======

A total of 30 elderly individuals completed the training program and all of the assessments and were subsequently included in the analysis. During the training period, thirteen subjects dropped out because of prolonged illnesses or time commitment ([Figure 1](#F1){ref-type="fig"}) and were excluded from analysis. None of the dropouts left the program as a result of injury or adverse responses to the training. The compliance with training prescription was 100% in the NWBV group and 91.39% in the HWVB group.

The characteristics of the final subject at baseline are represented in [Table 1](#T1){ref-type="table"}. Prior to the training, no significant differences between groups were observed for any variable.

###### 

Baseline characteristics of the sample.

                           **HWBV *N* = 10**    **NWBV *N* = 10**    **CON *N* = 10**      ***P***
  ------------------------ -------------------- -------------------- --------------------- ---------
  Age (years)              73.50(70.11−76.89)   69.00(65.21−72.79)   73.40(69.81−−76.99)   0.091
  BMI (kg⋅m^--2^)          28.86(25.85−31.86)   29.38(25.77−32.99)   28.86(26.35−31.36)    0.951
  Fat mass (%)             37.02(30.83−43.22)   34.11(27.37−40.86)   38.26(33.49−43.03)    0.529
  Lean mass (%)            62.98(56.78−69.17)   62.95(52.29−73.61)   61.74(56.97−66.50)    0.957
  Past BPAQ (score)        8.03(3.69−12.38)     10.17(4.23−16.11)    6.92(1.28−12.56)      0.619
  Total BMD (gr.cm^--2^)   1.061(0.977−1.145)   1.112(1.018−1.21)    1.034(0.968−1.100)    0.321
  Sex:                                                                                     0.155
  \- Male^a^               3(30.00%)            5(50.00%)            2(20.00%)             
  \- Female^a^             7(70.00%)            5(50.00%)            8(80.00%)             

Values expressed as Mean (95% Confidence Intervals).

P

values of analysis of variance (ANOVA).

a

values expressed as N (%).

P

values of analysis of Chi-square.

No significant differences were found for estimated calcium intake (*p* \> 0.05) in all groups between PRE (NWBV: 921.27 ± 419.30 mg/day; HWBV: 1124.30 ± 421.52 mg/day nor CON: 928.80 ± 291.89 mg/day) and POST (NWBV: 848.00 ± 229.81 mg/day; HWBV: 1186.80 ± 468.97 mg/day nor CON: 969.80 ± 392.73 mg/day) intervention.

Because of the neutral smell of the conditioned air, subjects could not tell if they were in hypoxia or normoxia. Blinding was successful as more than 60% of subjects guessed their group incorrectly.

The oxygen saturation was lower (*p* \< 0.01) for the hypoxia groups in all measured points during the training session. HR during the training sessions was not significantly different between groups ([Figure 2](#F2){ref-type="fig"}).

![Physiological challenges of oxygen saturation **(A)** and heart rate **(B)** controlled in the second minute of warm-up (warm up), before whole body vibration protocol (pre-training), between second and third set of whole body vibration protocol (mid-training) and after whole body vibration protocol (post-training). Significantly differences from HWBV: ^∗∗^*p* \< 0.01. Values are means and 95% Confidence Intervals. NWBV, normoxia whole body vibration group; HWBV, hypoxia whole body vibration group."](fphys-10-01122-g002){#F2}

Results of bone parameter responses after 18 weeks of intervention are shown in [Table 2](#T2){ref-type="table"}. Because of the responses to the training showed no sex differences, results for male and female participants were combined and analysed together. Changes in total and proximal femur BMD were not significantly different between groups. Two-way ANOVA indicated a borderline significant (*p* = 0.072) time x group interaction for total BMD and *post hoc* analysis revealed a slight but significant (*p* = 0.021) increase of this parameter after treatment in the HWBV group.

###### 

Bone Mineral Density measurement outcomes (g⋅cm^--2^) at baseline and after 18 weeks of normoxia-whole body vibration exercise (*N* = 10), combined hypoxia-whole body vibration exercise (*N* = 10) and in control group (*N* = 10).

                          **Baseline**             **Δ (%)**   **18 weeks**             **ES**   **SP**   **MDC (%)**   **ANOVA (p)**           
  ----------------------- ------------------------ ----------- ------------------------ -------- -------- ------------- --------------- ------- -------
  **Total**                                                                                                                                     
  NWBV                    1.112 (1.018--1.206)     --1.17      1.099 (1.005--1.193)     0.08     52.0     4.66          0.421           0.424   0.072
  HWBV                    1.061 (0.977--1.145)     \+ 3.58     1.099 (1.021--1.177)     0.35              6.75                                  
  CON                     1.034 (0.968--1.100)     \+ 0.68     1.041 (0.973--1.109)     0.11              2.38                                  
  **Total T-score**                                                                                                                             
  NWBV                    −0.967 (−2.379--0.446)   \+ 20.68    −1.167 (−3.175--0.841)   0.29     64.1     39.19         0.449           0.696   1.000
  HWBV                    −1.257 (−1.653--0.862)   --48.85     −0.643 (−1.099--0.187)   1.35              77.19                                 
  CON                     −0.950 (−1.861--0.039)   --10.53     −0.850 (−1.804--0.104)   0.09              32.59                                 
  **Femoral**                                                                                                                                   
  NWBV                    0.889 (0.792--0.986)     \+ 1.57     0.903 (0.809--0.997)     0.07     14.2     3.46          0.913           0.560   0.543
  HWBV                    0.837 (0.716--0.958)     \+ 1.19     0.847 (0.726--0.968)     0.06              1.76                                  
  CON                     0.830 (0.728--0.932)     0.96        0.838 (0.744--0.932)     0.07              6.91                                  
  **Femoral T-score**                                                                                                                           
  NWBV                    −0.744 (−1.383--0.106)   --13.44     −0.644 (−1.232--0.058)   0.13     10.4     26.63         0.877           0.658   0.684
  HWBV                    −1.070 (−1.840--0.300)   --3.74      −1.030 (−1.804--0.256)   0.04              15.60                                 
  CON                     −1.040 (−1.801--0.279)   --6.73      −0.970 (−1.697--0.243)   0.07              45.29                                 
  **Trochanter**                                                                                                                                
  NWBV                    0.697 (0.600--0.793)     \+ 1.00     0.704 (0.610--0.799)     0.00     65.5     4.67          0.126           0.527   1.000
  HWBV                    0.660 (0.556--0.764)     \+ 0.61     0.664 (0.560--0.768)     0.00              1.92                                  
  CON                     0.651 (0.570--0.732)     --2.00      0.638 (0.560--0.716)     0.09              5.85                                  
  **Intertrochanteric**                                                                                                                         
  NWBV                    1.048 (0.937--1.159)     \+ 2.48     1.074 (0.964--1.185)     0.14     57.0     3.76          0.798           0.369   0.670
  HWBV                    0.977 (0.846--1.108)     \+ 1.43     0.991 (0.857--1.125)     0.05              2.33                                  
  CON                     0.960 (0.845--1.075)     \+ 1.56     0.975 (0.872--1.078)     0.07              8.92                                  

Values expressed as Mean (95% Confidence Intervals). NWVB, normoxia whole body vibration group; HWBV, hypoxia whole body vibration group; CON, control group; Δ, absolute change; ES, effect size; SP, statistical power; MDC, minimum detectable change;

p

,

p

values.

[Figure 3](#F3){ref-type="fig"} shows the whole body and right proximal femur BMD individual responses after 18 weeks of intervention. Based on MDC, 30% of the subjects of HWBV group (3/10) reached this value in whole body BMD (MDC = 0.07 g⋅cm^--2^). In the femoral BMD, 70% (7/10) of the subjects reached the MDC following HWBV (MDC = 0.01 g⋅cm^--2^) and 30% (3/10) following NWBV (MDC = 0.03 g⋅cm^--2^). Fifty percent of the subjects (5/10) showed trochanter BMD changes equal of MDC after HWBV (MDC = 0.01 g⋅cm^--2^) and 20% (2/10) in the NWBV group. Thirty percent (3/10) of the subjects reached the MDC in the intertrochanteric region BMD following HWBV (MDC = 0.02 g⋅cm^--2^) and NWBV (MDC = 0.04 g⋅cm^--2^).

![Heterogeneity of whole-body BMD **(A)**, femoral *T*-score **(B)**, trochanter BMD **(C)** and intertrochanteric region BMD **(D)** values changes absolute, following whole body vibration alone (NWBV) and combined with normobaric hypoxia (HWBV). Dark dash line: minimal detectable change (MDC) to HWBV group; light dash line: minimal detectable change to NWBV group; ^∗^: intra-individual difference equal or greater than MDC (i.e., 0.07 g⋅cm^--\ 2^ of whole body BMD); Δ: absolute change (post- minus pre-training absolute change).](fphys-10-01122-g003){#F3}

Discussion {#S4}
==========

To the best of our knowledge, this is the first study evaluating the effects of prolonged (18 weeks) WBV training combined with normobaric cyclic hypoxic exposure on BMD in elderly people. WBV training under normobaric cyclic hypoxia tended to increase total BMD. Furthermore, the results indicate that the hypoxic stimulus combined with WBV training may cause an individualised response demonstrating effects in the proximal femur BMD after 18 weeks of treatment.

Our findings are similar to those reported by [@B5]. These researchers achieved the maintenance of bone density at the proximal femur after two sessions per week of low-frequency vibratory training and found a significant loss of trochanteric cortical density in their control group. Although BMD maintenance can be considered positive due to the fact that elderly adults face rapid bone loss ([@B28]), three times per week of WBV training could be necessary to obtain improvements in the hip region ([@B23]). Therefore, an higher amount of vibration exposure compared with that performed in the present study may cause larger effects ([@B19]). The combination of WBV training with physical activity and other therapies could decrease the participation for a population which is unable or unwilling to significantly increase their level of physical activity ([@B45]).

Based on the results of the present study, the WBV combined with normobaric cyclic hypoxia treatment tends to improve total BMD and to cause a greater individualised response regarding changes in the proximal femur BMD. In this context, subjects with BMD gains had a lower risk of fracture and those with BMD losses had a higher risk ([@B1]). Thus, 2--6% change in BMD is associated with a 15--40% decrease in fracture risk ([@B9]).

Although hip fracture is considered as most debilitating, profound loss of skeletal mass results in bone fragility and susceptibility to fractures at the spine, wrist and forearm as a result of falling ([@B25]). Thus, the increase/maintenance of whole body BMD is clinically relevant and could reduce the financial burden for public health. We hypothesised that the changes in total BMD observed before that of more specific regions, might be due to the effect of hypoxia, which was administered in a general manner being the subjects trained by breathing oxygen-depleted air. Unfortunately, there is limited research regarding the effect of cyclic hypoxic training on bone metabolism.

Previous authors have suggested that hypoxic training could enhance the physiological experience of training ([@B49]). Hypoxic stimulus and WBV training could have synergistic effects on bone metabolism. Only two studies previously have investigated the effects of hypoxic training on BMD. As in the results of this investigations healthy active adults showed improved total BMD after 8 weeks of normobaric hypoxic training ([@B33]). However, in trained triathletes, 7 weeks of normobaric cyclic hypoxia training at 15% PiO~2~ (2 days per week; 60 min per session) resulted in no reported changes in total BMD ([@B40]). In this sense, hypoxic protocols such as the one applied to the population that participated in the study could explain these different responses.

Based on *in vitro* studies, various mechanisms could explain the effects of hypoxia exposure on bone metabolism. Firstly, HIF-mediated upregulation of such glycolytic enzymes as pyruvate dehydrogenase kinase 1 (PDK1), lactate dehydrogenase A (LDHA) and glucose transporters (GLUTs) compensate for the energy inefficiency of glycolysis ([@B50]), since aerobic glycolysis is the main metabolic pattern during osteoblastic differentiation ([@B29]). Thus, hypoxia exposure might enhance bone formation by promoting glycolysis as the main metabolic pathway. However, high bone mass does not depend solely on glycolysis ([@B15]). HIF also regulates bone remodelling-involved genes such as vascular endothelial growth factor (VEGF), erythropoietin (EPO) and osteoprotegerin (OPG), the factor that inhibits osteoclastogenesis by counteracting RANKL and therefore bone reabsorption ([@B65]). VEGF represents a key player in the coupling of angiogenesis and osteogenesis ([@B15]) and in promoting osteogenesis ([@B18]; [@B22]). EPO has also been shown to stimulate bone formation and repair ([@B64]).

On the other hand, some studies demonstrated that hypoxic exercise, similarly to exercise performed in normoxia, augments oxidative stress ([@B14]). The effects of oxidative stress caused by WBV training in hypoxic environment on bone metabolism remains to be investigated; however, moderate cyclic hypoxia protocols may reinforce the immune system, while suppressing the production of pro-inflammatory mediators in the bone systems ([@B52]). Rats exposed to cyclic hypoxia (10 min, 13% O~2~, 10-min intervals, 4 h/day, 28 days) had increased alkaline phosphatase activity ([@B30]) due to high osteoblast activity increasing new bone formation. Moreover, rats exposed to hypobaric cyclic hypoxia (430 mmHg, 34 mmHg PaO~2~; 5 h/day, 5 days/week, 5 weeks) showed higher BMD levels ([@B22]). These effects in rats may result from increased nitric oxide levels ([@B38]). Increased reactive oxygen species production will activate pro-inflammatory cytokines, which cause production of NO in osteoblasts and osteoclasts, among other cells. It is known that NO regulates osteoclast-mediated bone resorption, activates osteoblastic activity and inhibits RANKL expression ([@B16]; [@B61]). As a result of all these mechanisms, moderate cyclic hypoxia protocols may inhibit osteoclastic activity and/or stimulate osteoblastic activity; nevertheless, more research is needed to understand these mechanisms ([@B38]).

Several limitations deserve comment. Most important, the sample size of the present investigation is relatively small; this might explain why we were not able to detect significant changes between the groups. The calculation of sample size *a priori* could be crucial in clinical studies to be able to generalise the obtained result to the overall population ([@B27]). Unfortunately, our sample size was limited due to logistic conditions (availability of rooms, devices, etc.). Thus, power analysis was performed *a posteriori*, which permits knowing the likelihood of having significant effect, given the observed effect size, sample size and predetermined critical significance level. Due to difficulties in getting participants from this population, who have problems with their mobility or do not like physical activity ([@B8]), both men and women were included in this study, resulting in different numbers of males and females. Chi-square tests showed that the groups were homogeneous at baseline regarding sex. Furthermore, as no sex by training interactions were found, the results for male and female participants were combined and analysed together. Additionally, we did not measure the serum and urinary levels of bone metabolism markers, which could offer more information about the effect of normobaric cyclic hypoxic exposure and WBV training on bone metabolism. Assessment of molecular signaling pathways during cyclic hypoxia exposure could also help to elucidate mechanisms responsible for adaptations. On the other hand, although DXA is the most widely used bone densitometry technique among the reported studies, the ability of peripheral quantitative computed tomography (pQCT) to assess bone geometric properties may prove advantageous in evaluating the effects of treatment on bone health ([@B19]). However, the sensitivity of those instruments in detecting subtle exercise-induced changes in bone geometry has not been exhaustively tested. Bone geometry could be monitored by DXA-derived BMD and this technique could provide appropriate information to design optimal therapeutic exercise programmes ([@B25]). Finally, results were obtained in the context of an 18-week trial, and more long-term clinical effects remain unknown. Research on the effects of the training concluded that regarding bone mass among elderly people, continued exercise training is needed to maintain bone mass ([@B19]).

Conclusion {#S5}
==========

An 18-week WBV training with hypoxic stimuli tended to generate positive effects on BMD in the elderly population. Although changes did not differ significantly between groups, the benefits observed within the WBV plus hypoxia group may be promising, but need to be confirmed in future large-scale studies. WBV training generates shear stresses on the bone cells, and this might be enhanced by effects related to the hypoxic stimuli. Future research will provide a deeper understanding of mechanisms responsible for the effects of normobaric hypoxia combined with WBV training.
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